Jordan VC - Search Results

1

Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor.

Levenson AS, Svoboda KM, Pease KM, Kaiser SA, Chen B, Simons LA, Jovanovic BD, Dyck PA, Jordan VC. Levenson AS, et al. Among authors: jordan vc. Cancer Res. 2002 Aug 1;62(15):4419-26. Cancer Res. 2002. PMID: 12154049

2

MCT-1 oncogene contributes to increased in vivo tumorigenicity of MCF7 cells by promotion of angiogenesis and inhibition of apoptosis.

Levenson AS, Thurn KE, Simons LA, Veliceasa D, Jarrett J, Osipo C, Jordan VC, Volpert OV, Satcher RL Jr, Gartenhaus RB. Levenson AS, et al. Among authors: jordan vc. Cancer Res. 2005 Dec 1;65(23):10651-6. doi: 10.1158/0008-5472.CAN-05-0845. Cancer Res. 2005. PMID: 16322206

3

Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER alpha.

Levenson AS, Gehm BD, Pearce ST, Horiguchi J, Simons LA, Ward JE 3rd, Jameson JL, Jordan VC. Levenson AS, et al. Among authors: jordan vc. Int J Cancer. 2003 May 1;104(5):587-96. doi: 10.1002/ijc.10992. Int J Cancer. 2003. PMID: 12594813

4

Estrogenic activity is increased for an antiestrogen by a natural mutation of the estrogen receptor.

Levenson AS, Catherino WH, Jordan VC. Levenson AS, et al. Among authors: jordan vc. J Steroid Biochem Mol Biol. 1997 Mar;60(5-6):261-8. doi: 10.1016/s0960-0760(96)00184-7. J Steroid Biochem Mol Biol. 1997. PMID: 9219916

5

MCF-7: the first hormone-responsive breast cancer cell line.

Levenson AS, Jordan VC. Levenson AS, et al. Among authors: jordan vc. Cancer Res. 1997 Aug 1;57(15):3071-8. Cancer Res. 1997. PMID: 9242427 No abstract available.

6

Agonist activity of antiestrogen-receptor complexes to regulate urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) endogenous gene expression in breast cancer cells.

Levenson AS, Svoboda KM, Kwaan HC, Jordan VC. Levenson AS, et al. Among authors: jordan vc. Cancer Lett. 1998 Mar 13;125(1-2):215-20. doi: 10.1016/s0304-3835(97)00516-8. Cancer Lett. 1998. PMID: 9566718

7

The key to the antiestrogenic mechanism of raloxifene is amino acid 351 (aspartate) in the estrogen receptor.

Levenson AS, Jordan VC. Levenson AS, et al. Among authors: jordan vc. Cancer Res. 1998 May 1;58(9):1872-5. Cancer Res. 1998. PMID: 9581827

8

Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor.

Levenson AS, Kwaan HC, Svoboda KM, Weiss IM, Sakurai S, Jordan VC. Levenson AS, et al. Among authors: jordan vc. Br J Cancer. 1998 Jul;78(1):88-95. doi: 10.1038/bjc.1998.447. Br J Cancer. 1998. PMID: 9662256 Free PMC article.

9

The oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptor.

Levenson AS, Tonetti DA, Jordan VC. Levenson AS, et al. Among authors: jordan vc. Br J Cancer. 1998 Jun;77(11):1812-9. doi: 10.1038/bjc.1998.301. Br J Cancer. 1998. PMID: 9667651 Free PMC article.

10

Selective oestrogen receptor modulation: molecular pharmacology for the millennium.

Levenson AS, Jordan VC. Levenson AS, et al. Among authors: jordan vc. Eur J Cancer. 1999 Nov;35(12):1628-39. doi: 10.1016/s0959-8049(99)00183-5. Eur J Cancer. 1999. PMID: 10674006 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

596 results

Search Page

Filters